CRINONE

This brand name is authorized in Australia, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug CRINONE contains one active pharmaceutical ingredient (API):

1 Progesterone UNII 4G7DS2Q64Y - PROGESTERONE

Progesterone is a natural progestogen, the main hormone of the corpus luteum and the placenta. It acts on the endometrium by converting the proliferating phase to the secretory phase. Read about Progesterone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CRINONE Vaginal gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03DA04	Progesterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DA Pregnen (4) derivatives
Discover more medicines within G03DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 6366C
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525421601164310, 525421602160319
Country: CA	Health Products and Food Branch	Identifier(s): 02241013
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2385-MEE-0816
Country: EE	Ravimiamet	Identifier(s): 1134548, 1634846, 1634857, 1765919, 1765920
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 62915
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 053843
Country: FR	Base de données publique des médicaments	Identifier(s): 65015968
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 42123
Country: HK	Department of Health Drug Office	Identifier(s): 44527
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-302863360
Country: IE	Health Products Regulatory Authority	Identifier(s): 18927, 18928, 36553, 54352
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6538
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1072219, 1076147, 1093375
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 303M97
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 129402
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10232
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100339095, 100459097
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W61888001, W61888002
Country: SG	Health Sciences Authority	Identifier(s): 10884P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699777342035
Country: US	FDA, National Drug Code	Identifier(s): 0023-6150, 0023-6151, 52544-256
Country: ZA	Health Products Regulatory Authority	Identifier(s): A38/21.8.2/0615